The Baksan Experiment on Sterile Transitions (BEST) was designed to investigate the deficit of electron neutrinos νe observed in previous gallium-based radiochemical measurements with high-intensity ...neutrino sources, commonly referred to as the "gallium anomaly," which could be interpreted as evidence for oscillations between νe and sterile neutrino (νs) states. A 3.414-MCi 51Cr νe source was placed at the center of two nested Ga volumes and measurements were made of the production of 71Ge through the charged current reaction, 71Ga(νe,e-)71Ge, at two average distances. The measured production rates for the inner and the outer targets, respectively, are 54.9$_{-2.4}^{+2.5}$(stat)±1.4(syst) and 55.6$_{-2.6}^{+2.7}$(stat)±1.4(syst) atoms of 71Ge/d. The ratio (R) of the measured rate of 71Ge production at each distance to the expected rate from the known cross section and experimental efficiencies are Rin=0.79±0.05 and Rout=0.77±0.05. The ratio of the outer to the inner result is 0.97±0.07, which is consistent with unity within uncertainty. The rates at each distance were found to be similar, but 20%-24% lower than expected, thus reaffirming the anomaly. Therefore these results are consistent with νe→νs oscillations with a relatively large Δm2 (> 0.5 eV2) and mixing sin22θ (≈0.4).
Excitotoxicity in the brain is a causal factor in several neurological and neurodegenerative disorders. Excitatory amino acid transporter 2 (EAAT2), an astrocytic glutamate transporter involved in ...the clearance of >80% of synaptic glutamate, is considered a therapeutically relevant target for excitotoxicity. We have previously designed GT951, an activator of EAAT2 with nanomolar efficacy but limited in vivo bioavailability. In this study, a pharmacophore-based screening and optimization resulted in the design of GTS467 and GTS511. GTS467 and GTS511 have low nanomolar efficacy in the glutamate uptake assay. Pharmacokinetic profiles (PK) of GTS511 show a >6 h half-life and higher bioavailability in plasma and the brain under all three routes of administration in rats. Similarly, GTS467 has high oral bioavailability (80–85%) in the brain and plasma with a >1 h half-life under all three dosing routes. These encouraging efficacy and PK profiles suggest that GTS511 and GTS467 can be further developed to treat neurological disorders caused by excitotoxicity.
New data on the production of charged kaons in p+p interactions are presented. The data come from a sample of 4.8 million inelastic events obtained with the NA49 detector at the CERN SPS at 158 GeV/c ...beam momentum. The kaons are identified by energy loss in a large TPC tracking system. Inclusive invariant cross sections are obtained in intervals from 0 to 1.7 GeV/c in transverse momentum and from 0 to 0.5 in Feynman x. Using these data as a reference, a new evaluation of the energy dependence of kaon production, including neutral kaons, is conducted over a range from 3 GeV to
collider energies.
The influence of temperature on the quality of the graphite lubricant layer on the surface of the working part of a mandrel is addressed. In order to modernize the cooling system of the mandrels of a ...continuous mill in automatic mode so as to equalize the temperature along the length of their working part, the cooling stage of the working parts under standard conditions is analyzed, along with determining the sections where the major deformation occurs. The results of the pilot implementation of a new cooling system in the discussed tooling are demonstrated.
Display omitted
L-Cysteine hydrochloride (CysCl) has been found to be an effective additive to hybrid halide perovskites, improving both the quality of perovskite films and the operando parameters of ...perovskite solar cells. The origin of the CysCl effect on the mixed-cation hybrid halide perovskite and related photovoltaic devices has been disclosed.
New data on the production of protons, anti-protons and neutrons in p+p interactions are presented. The data come from a sample of 4.8 million inelastic events obtained with the NA49 detector at the ...CERN SPS at 158 GeV/c beam momentum. The charged baryons are identified by energy loss measurement in a large TPC tracking system. Neutrons are detected in a forward hadronic calorimeter. Inclusive invariant cross sections are obtained in intervals from 0 to 1.9 GeV/c (0 to 1.5 GeV/c) in transverse momentum and from −0.05 to 0.95 (−0.05 to 0.4) in Feynman
x
for protons (anti-protons), respectively.
p
T
integrated neutron cross sections are given in the interval from 0.1 to 0.9 in Feynman
x
. The data are compared to a wide sample of existing results in the SPS and ISR energy ranges as well as to proton and neutron measurements from HERA and RHIC.
New results on the production of charged pions in p+p interactions are presented. The data come from a sample of 4.8 million inelastic events obtained with the NA49 detector at the CERN SPS at 158 ...GeV/c beam momentum. Pions are identified by energy loss measurement in a large TPC tracking system which covers a major fraction of the production phase space. Inclusive invariant cross sections are given on a grid of nearly 300 bins per charge over intervals from 0 to 2 GeV/c in transverse momentum and from 0 to 0.85 in Feynman x. The results are compared to existing data in overlapping energy ranges.
NICA is the new accelerator complex being under design and construction at JINR. The facility is aimed at providing collider experiments with heavy ions up to Uranium in a center of mass energy range ...from 4 to 11 GeV/u and an average luminosity up to 10 27 cm -2 · s -1 . The collisions of polarized deuterons are also foreseen. The facility includes two injector chains, a new superconducting Booster synchrotron, the existing 6 A · GeV superconducting synchrotron-Nuclotron, and the new superconducting Collider consisting of two rings of about 500 m circumference each. The Booster synchrotron and the NICA Collider are based on an iron-dominated "window frame"- type magnet with a hollow superconductor winding analogous to the Nuclotron magnet. The status of the design and construction of the full size model magnets for the Booster synchrotron as well as for the NICA Collider is presented.
The PROTAC (
PROteolysis TArgeting Chimera
) technology is a method of targeting intracellular proteins previously considered undruggable. This technology utilizes the ubiquitin—proteasome system in ...cells to specifically degrade target proteins, thereby offering significant advantages over conventional small-molecule inhibitors of the enzymatic function. Preclinical and preliminary clinical trials of PROTAC-based compounds (degraders) are presented. The review considers the general principles of the design of degraders. Advances and challenges of the PROTAC technology are discussed.
PDF
